Cytodyn Inc (CYDY)

[Scooter McCabe]

POTENTIAL DEATH BLOW TO CYDY

CYTODYN, CYDY, claims to be a late stage biotech company despite nothing to show for it, has long claimed to have a revenue deal for COVID in the Philippines at hand. However recent setbacks have forced CYDY to admit that revenue there is on the backburner despite having agreements in place, allegedly.

Today Humanigen, HGEN, an actual late stage biotech, has announced two major partnerships. One in Korea. The other in the Philippines. Upon receiving an EUA from FDA, HGEN will be able to receive one from the PFDA and sell it's drug in the Philippines....

This would essentially cut CYDY from every major market it intended to peddle it's unproven drug in. The Philippines has specifically been CYDY's major focus and hope for beginning a revenue stream. By losing out on being first to market in that country and the US, CYDY will be revenue starved. They will also lose out on any future EUAs because their competitor treats COVID further upstream than CYDY does eliminating the need for the drug. At the very least there is no longer a justification for an EUA as a need has been filled.

With the lion's share of CYDY's cash spent on COVID, the loss of this market throws CYDY's hopes on HIV. However Nader in all his wisdom decided to put getting the HIV BLA on the backburner. Pushing off the closest potential revenue stream all the way back to October where CYDY is set to run out of money. Again it was Nader's call to throw all of CYDY's eggs in the COVID basket, miss and now place the company on a collision course with bankruptcy and dissolution.

Meanwhile Humanigen, a company who Nader has mocked in several conference calls, took all the right steps. Partnering with major organization like the NIH, taking part in Operation Warp Speed, and filling out it's board with experienced Phrama people. The irony of Nader stating "Humanigen doesn't have enough production facilities" is palpable as CYTODYN is likely to have no facilities at all after being shut out of the market.

Proof that CYDY has lost the one market it threw all it's hopes on.

The 13D group is now likely a moot point unless they are bringing fresh funding. CYTODYN has been strategically decapitated from the market through astute competition and criminal incompetence by it's own management.

The alarm bell was rung well over a year ago about CYTODYN, the company where dreams go to die, and now the end is near.